These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5917155)

  • 41. [Case of herpes zoster and varicella in a child].
    Hadzić M; Kujundzić M
    Srp Arh Celok Lek; 1975 Oct; 103(10):895-8. PubMed ID: 1228914
    [No Abstract]   [Full Text] [Related]  

  • 42. Prevention strategies: experience of varicella vaccination programmes.
    Patrick D
    Herpes; 2007 Sep; 14 Suppl 2():48-51. PubMed ID: 17939897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The epidemiology of varicella-zoster virus infections.
    Wharton M
    Infect Dis Clin North Am; 1996 Sep; 10(3):571-81. PubMed ID: 8856352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Varicella-zoster virus: a re-emerging infection.
    LaGuardia JJ; Gilden DH
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):183-7. PubMed ID: 11924825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stroke after varicella and zoster ophthalmicus: another indication for treatment and immunization.
    Grose C
    Pediatr Infect Dis J; 2010 Sep; 29(9):868-9. PubMed ID: 20395879
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical and pathogenetic aspects of varicella-zoster.
    Plotkin SA
    Postgrad Med J; 1985; 61 Suppl 4():7-14. PubMed ID: 3014481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Varicella-zoster in Sydney. II. Neurological complications of varicella.
    Boughton CR
    Med J Aust; 1966 Sep; 2(10):444-7. PubMed ID: 5917530
    [No Abstract]   [Full Text] [Related]  

  • 48. Acyclovir resistant varicella zoster and HIV infection.
    Lyall EG; Ogilvie MM; Smith NM; Burns S
    Arch Dis Child; 1994 Feb; 70(2):133-5. PubMed ID: 8129436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles.
    Schuette MC; Hethcote HW
    Bull Math Biol; 1999 Nov; 61(6):1031-64. PubMed ID: 17879870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical herpes zoster shortly following primary varicella in two HIV-infected children.
    Patterson LE; Butler KM; Edwards MS
    Clin Pediatr (Phila); 1989 Aug; 28(8):354. PubMed ID: 2547541
    [No Abstract]   [Full Text] [Related]  

  • 51. [Chickenpox and herpes zoster. Epidemiology, physiopathology, diagnosis, development, treatment].
    Raffi F
    Rev Prat; 1993 Apr; 43(8):1023-7. PubMed ID: 8341968
    [No Abstract]   [Full Text] [Related]  

  • 52. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.
    Gao Z; Gidding HF; Wood JG; MacIntyre CR
    Epidemiol Infect; 2010 Apr; 138(4):457-68. PubMed ID: 19781116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology of Varicella-Zoster Virus in England and Wales.
    Brisson M; Edmunds WJ
    J Med Virol; 2003; 70 Suppl 1():S9-14. PubMed ID: 12627480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in U.S. Community hospitalizations due to herpes zoster: 2001-2015.
    Pham MA; Bednarczyk RA; Becker ER; Orenstein WA; Omer SB
    Vaccine; 2019 Feb; 37(6):882-888. PubMed ID: 30616954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Varicella in patients infected with the human immunodeficiency virus.
    Perronne C; Lazanas M; Leport C; Simon F; Salmon D; Dallot A; Vildé JL
    Arch Dermatol; 1990 Aug; 126(8):1033-6. PubMed ID: 2166482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
    Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
    Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Varicella-zoster infections.
    Hanshaw JB; Dudgeon JA
    Major Probl Clin Pediatr; 1978; 17():192-208. PubMed ID: 202811
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Varicella-zoster virus infections: chronic disease in the immunocompromised host: evidence for persistent excretion of virus.
    Whitley RJ
    Pediatr Infect Dis J; 1989 Sep; 8(9):584-5. PubMed ID: 2552389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.